1000018-44-9

Upstream product

• 141-91-3 2,6-dimethyl morpholine 
• 2516-95-2 5-chloro-2-nitrobenzoic acid 

Downstream Products

• 1092536-66-7 2-amino-5-(2,6-dimethylmorpholin-4-yl)benzoic acid 
• 1092536-72-5 1,2-diamino-3-cyano-4-benzylamino-6-(2,6-dimethylmorpholin-4-yl)quinolinium tosylate 
• 1092536-65-6 2-(4-methoxyphenyl)-7-(2,6-dimethylmorpholin-4-yl)-5-benzylamino-4-cyano-s-triazolo[1,5-a]quinoline 
• 1092536-70-3 2-amino-3-cyano-4-benzylamino-6-(2,6-dimethylmorpholin-4-yl)quinoline 

Relevant academic research and scientific papers

TRIAZOLO [1, 5-A] QUINOLINES AS ADENOSINE A3 RECEPTOR LIGANDS

The present invention relates to the adenosine A3 receptor ligands of the general formula (I), within them favourably to the antagonists, to their salts, solvates, N-oxides and isomers, to the pharmaceutical compositions containing the compounds of the general formula (I), their salts, solvates, N-oxides and isomers, to the use of the compounds of the general formula (I), their salts, solvates, N-oxides and isomers, to the preparation of the compounds of the general formula (I), their salts, solvates, N-oxides and isomers, as well as to the new intermediates of the general formula (II), (VI), (XI), (XII) and (XV), and to the preparation thereof.